Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin adjunctive therapy in infants and young children with partial onset seizures
2013-003420-37Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in Focal Onset Epilepsy and Focal onset seizure (3 arms), sponsored by Pfizer. Primary endpoint: Primary efficacy endpoint. Started Mar 2014; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal Onset EpilepsyFocal onset seizure
Beyond the preview
Go deeper on 2013-003420-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003420-37.